Eukedos SpA

Eukedos SpA has a highly leveraged capital structure, with a debt-to-equity ratio of 4.17, indicating a significant reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.21 and only 21,000 EUR in cash and equivalents, which is far below the long-term debt of 121,471,000 EUR. The negative net cash position further exacerbates liquidity concerns. Profitability metrics are underperforming relative to industry norms. The company reported a net loss of 749,000 EUR and a negative return on equity of -2.57%, which is far below the typical performance of firms in the healthcare services and equipment sector. Operating income of 5,403,000 EUR is modest given the company's asset base of 180,333,000 EUR, resulting in a return on assets of -0.42%. The company's revenue is derived from three segments: Medical Devices, Equipment, and Contract. However, the financial data does not provide a breakdown of revenue by segment or geography, making it difficult to assess concentration risk or geographic exposure. The lack of segmental data limits the ability to evaluate the performance of individual business lines or regions. The company's growth trajectory is uncertain. While the most recent actual revenue of 52,907,000 EUR is slightly higher than the reported 51,639,000 EUR, the net loss and negative free cash flow of -798,000 EUR suggest operational challenges. The capital expenditure of -5,800,000 EUR indicates ongoing investment, but the negative free cash flow suggests that these investments are not yet generating sufficient returns. Risk factors include liquidity constraints and the potential for dilution, although the risk of dilution is currently assessed as low. The company's high debt load and weak liquidity position increase the risk of financial distress, particularly if operating cash flows do not improve. Recent events include the filing of financial data that shows a net loss and weak liquidity. No recent earnings call transcripts or significant regulatory filings have been disclosed in the provided data.